Series B - Purespring Therapeutics - 2024-10-09 - Crunchbase

Purespring Therapeutics raised $104711631 on 2024-10-09 in Series B. Sofinnova Partners Sofinnova Partners is a venture capital firm that invests in the life sciences sector, from seed …

CouponFollow Extension

$104711631
OFF

Series B - Purespring Therapeutics - 2024-10-09 - Crunchbase

6 days from now

Purespring Therapeutics raised $104711631 on 2024-10-09 in Series B. Sofinnova Partners Sofinnova Partners is a venture capital firm that invests in the life sciences sector, from seed …

crunchbase.com

$105
OFF

Purespring Therapeutics Raises $105M In Series B Financing

6 days from now

Oct 9, 2024 · Purespring will present its IgAN data publicly for the first time at the American Society of Nephrology (ASN) Kidney Week congress on October 26 in San Diego (abstract …

finsmes.com

$105
OFF

Purespring Bottles Up $105M Series B For Kidney Gene Therapy

6 days from now

Oct 9, 2024 · London-based biotech Purespring Therapeutics plans to bring their kidney-tweaking gene therapy to the clinic with the help of a new £80 million (about $105 million) pool of series …

fiercebiotech.com

$105
OFF

Purespring Therapeutics Secures £80/$105M In Series B Funding …

6 days from now

Oct 9, 2024 · Purespring Therapeutics, a pioneering gene therapy company specializing in transforming the treatment of kidney diseases, has recently secured £80/$105 million in a …

ainvest.com

$105
OFF

Purespring Therapeutics Raised A $105M Series B Earlier This Month …

6 days from now

Oct 24, 2024 · Purespring Therapeutics raised a $105M series B earlier this month to advance AAV gene therapies for kidney diseases, including both monogenic and non-monogenic …

biotechtv.com

$105
OFF

Purespring Therapeutics Raises £80/$105 Million In A Series B …

6 days from now

London – 9 October 2024 – Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …

purespringtx.com

£80
OFF

Purespring Therapeutics Series B Financing – Company …

6 days from now

9 October 2024 Syncona Limited Purespring Therapeutics raises £80 million in a Series B financing · Purespring raises £80 million in a Series B financing, with Syncona committing …

ft.com

$105
OFF

Purespring Therapeutics Raises £80/$105 Million In A Series B …

6 days from now

London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …

businessinsider.com

$15000000
OFF

Series B - Spry - 2024-10-09 - Crunchbase Funding Round Profile

6 days from now

Oct 9, 2024 · Spry raised $15000000 on 2024-10-09 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension ... The Economic Times — Software-as-a-service startup Spry …

crunchbase.com

£45
OFF

Syncona Founds Purespring With A £45m Series A Financing

6 days from now

Jul 30, 2021 · Syncona Ltd, a leading healthcare company focused on founding, building and funding a portfolio of global leaders in life science, announces the foundation of a new …

purespringtx.com

$48578955
OFF

Series B - CorFlow Therapeutics AG - 2024-09-10 - Crunchbase

6 days from now

Sep 10, 2024 · CorFlow Therapeutics AG raised $48578955 on 2024-09-10 in Series B. Search Crunchbase. Start Free Trial ... Organization Name . CorFlow Therapeutics AG . Announced …

crunchbase.com

$105
OFF

Purespring Therapeutics Raises £80/$105 Million In A Series B …

6 days from now

London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …

synconaltd.com

$59613150
OFF

Series A - Purespring Therapeutics - 2020-11-19 - Crunchbase

6 days from now

Purespring Therapeutics raised $59613150 on 2020-11-19 in Series A. Syncona Partners LLP Syncona Partners LLP is a healthcare company focused on investing in and building global …

crunchbase.com

FAQs about Series B - Purespring Therapeutics - 2024-10-09 - Crunchbase Coupon?

Does purespring therapeutics have a series B financing?

Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde Healthcare, Forbion, British Patient Capital and founding investor Syncona ...

Who is purespring Therapeutics?

Purespring Therapeutics is an AAV gene therapy company focused on the kidney globally. ...

Does purespring therapeutics have a kidney nephropathy program?

Biotechnology company Purespring Therapeutics has raised about $105 million to fund its development of gene therapies for diseases of the kidney. The Series B funding announced Wednesday was led by Sofinnova Partners and will support Purespring’s initiation of a Phase 1/2 study of its lead candidate for IgA nephropathy, or IgAN. ...

Will purespring's Series B round fund IgA nephropathy treatment?

The Series B round will fund a Phase 1/2 trial of the company’s experimental treatment for IgA nephropathy. PureSpring’s lead drug candidate is designed to treat IgA nephropathy, a rare kidney disease. Jian Fan via Getty Images ...

Will purespring bring kidney-tweaking gene therapy to the clinic?

London-based biotech Purespring Therapeutics plans to bring their kidney-tweaking gene therapy to the clinic with the help of a new £80 million (about $105 million) pool of series B cash. ...

What will ps-002 funding mean for purespring?

The funds raised will allow us to bring our novel treatments to patients in the clinic.” The funds will filter to drugs throughout Purespring’s pipeline, including lead asset PS-002, which is being developed for IgA nephropathy, a disease caused by a build-up of immunoglobulin A in the kidneys. ...